Stock Trading Signals

Profitable stock trading signals for traders

(DRNA) Dicerna Prescription drugs is Resumed by H.C. Wainwright to Purchase, Value Goal at $5

Dicerna Pharmaceuticals (DRNA) is Resumed by H.C. Wainwright to Buy and the brokerage firm has set the Price Target at $5. The Rating was issued on May-23-2017.

(SHOP) Shopify is Resumed by Credit score Suisse to Outperform, Value Goal at $95

Shopify (SHOP) is Resumed by Credit Suisse to Outperform and the brokerage firm has set the Price Target at $95. The Rating was issued on May-23-2017.

(ELY) Callaway Golf Reiterated by Imperial Capital to Outperform, Raises Value Goal to $14.50

Callaway Golf (ELY) is Reiterated by Imperial Capital to Outperform and the brokerage firm has raised the Price Target to $14.50 from a previous price target of $13 . The…

(WLK) Westlake Chemical Reiterated by Cowen to Outperform, Raises Value Goal to $70

Westlake Chemical (WLK) is Reiterated by Cowen to Outperform and the brokerage firm has raised the Price Target to $70 from a previous price target of $66 . The Rating…

(EGHT) eight×eight is Reiterated by Dougherty & Firm to Purchase, Lowers Value Goal to $16

8×8 (EGHT) is Reiterated by Dougherty & Company to Buy while Lowering the Price Target of the company shares to $16 from a previous price target of $18 . The…

(DXCM) Dexcom is Resumed by Piper Jaffray to Obese

Dexcom (DXCM) is Resumed by Piper Jaffray to Overweight. The Rating was issued on May-22-2017.

(PODD) Insulet is Resumed by Piper Jaffray to Chubby

Insulet (PODD) is Resumed by Piper Jaffray to Overweight. The Rating was issued on May-22-2017.

(CHGG) Chegg Reiterated by First Evaluation Sec to Chubby, Raises Value Goal to $14

Chegg (CHGG) is Reiterated by First Analysis Sec to Overweight and the brokerage firm has raised the Price Target to $14 from a previous price target of $12 . The…

(SRNE) Sorrento Therapeutics is Reiterated by FBR & Co. to Outperform, Lowers Value Goal to $9

Sorrento Therapeutics (SRNE) is Reiterated by FBR & Co. to Outperform while Lowering the Price Target of the company shares to $9 from a previous price target of $13 .…

1 2 3 92